MedPath
FDA Approval

Testosterone Cypionate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 14, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Testosterone cypionate(200 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

HIKMA FARMACEUTICA (PORTUGAL), S.A

Hikma Pharmaceuticals USA Inc.

452742943

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Testosterone Cypionate

Product Details

NDC Product Code
0143-9659
Application Number
ANDA091244
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR
Effective Date
March 14, 2022
Code: M0XW1UBI14Class: ACTIBQuantity: 200 mg in 1 mL
BENZYL ALCOHOLInactive
Code: LKG8494WBHClass: IACTQuantity: 9.45 mg in 1 mL
COTTONSEED OILInactive
Code: H3E878020NClass: IACTQuantity: 560 mg in 1 mL
BENZYL BENZOATEInactive
Code: N863NB338GClass: IACTQuantity: 0.2 mL in 1 mL

Testosterone Cypionate

Product Details

NDC Product Code
0143-9726
Application Number
ANDA091244
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR
Effective Date
March 14, 2022
Code: M0XW1UBI14Class: ACTIBQuantity: 200 mg in 1 mL
BENZYL BENZOATEInactive
Code: N863NB338GClass: IACTQuantity: 0.2 mL in 1 mL
COTTONSEED OILInactive
Code: H3E878020NClass: IACTQuantity: 560 mg in 1 mL
BENZYL ALCOHOLInactive
Code: LKG8494WBHClass: IACTQuantity: 9.45 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath